Inactive Instrument

News Spring Bank Pharmaceuticals, Inc.

Equities

SBPH

US8494311017

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

F-STAR THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20-11-25	AQ
Spring Bank Pharmaceuticals : F-star Therapeutics Announces Approval of Clinical Trial Application for FS222	20-11-24	PU
Spring Bank Pharmaceuticals : F-star Therapeutics Completes Combination with Spring Bank Pharmaceuticals	20-11-22	PU
Spring Bank Pharmaceuticals : F-star Therapeutics to Present New Clinical and Mechanistic Data on its LAG-3/PD-L1 Tetravalent Bispecific Antibody, FS118, at the SITC 2020 Virtual Annual Meeting	20-11-22	PU
F-STAR THERAPEUTICS, INC. : Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Changes in Registrant's Certifying Accountant, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	20-11-20	AQ
Spring Bank Pharmaceuticals, Inc. has Changed its Name to F-star Therapeutics, Inc	20-11-20	CI
Spring Bank Pharmaceuticals : Stockholders Approve Combination with F-star Therapeutics	20-11-20	AQ
F-Star Therapeutics Limited completed the acquisition of Spring Bank Pharmaceuticals, Inc. in a reverse merger transaction.	20-11-19	CI
Spring Bank Pharmaceuticals : Stockholders Approve Combination with F-star Therapeutics	20-11-19	AQ
Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics	20-11-19	GL
SPRING BANK PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	20-11-09	AQ
Spring Bank Pharmaceuticals : Announces Special Dividend of Contingent Value Rights	20-11-06	AQ
Spring Bank Pharmaceuticals Announces Special Dividend of Contingent Value Rights	20-11-06	GL
SPRING BANK PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	20-11-03	AQ
Spring Bank Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-03	CI
Spring Bank Pharmaceuticals : Announces Poster Presentation at the 2020 Society for Immunotherapy of Cancer Annual Meeting	20-11-03	AQ
Spring Bank Pharmaceuticals : Announces Poster Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting	20-11-02	AQ
Spring Bank Announces Poster Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting	20-11-02	GL
Spring Bank Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-10	CI
SPRING BANK PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	20-08-10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Spring Bank Pharmaceuticals, Inc.

Equities

SBPH

US8494311017

Summary

Filters